After winning an approval decades in the making last year—and shuffling its executive roster throughout 2025—Geron Corporation is scaling back its head count.
https://www.fiercepharma.com/pharma/geron-lay-13-workforce-quest-slash-operating-costs-maximize-rytelo-launch